2018
DOI: 10.37358/rc.18.3.6168
|View full text |Cite
|
Sign up to set email alerts
|

Long Term Efficacy of the Treatment with Olanzapine Pamoate, Risperidone and Aripiprazole Monohydrate

Abstract: The use of long-acting injectable antipsychotics (LAIs) is considered to be an important treatment option, especially in early stages of schizophrenia. The aim of this study was to evaluate the efficacy, safety and sustained remission in schizophrenia patients treated with three of the available LAIs substances: olanzapine pamoate, risperidone microspheres and aripiprazole monohydrate. A retrospective chart review study evaluating the efficacy of LAIs compared to oral antispychotics during a five years period … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…Underuse of clozapine and overuse of antipsychotic polypharmacy have been both associated with poor quality of care [12][13][14]. One of the reasons of clozapine underuse is the inconsistence of the reports concerning clozapine oral dose and serum level.…”
mentioning
confidence: 99%
“…Underuse of clozapine and overuse of antipsychotic polypharmacy have been both associated with poor quality of care [12][13][14]. One of the reasons of clozapine underuse is the inconsistence of the reports concerning clozapine oral dose and serum level.…”
mentioning
confidence: 99%